LFCR logo

LFCR

Lifecore Biomedical Inc.

$5.12
+$0.04(+0.79%)
35
Overall
20
Value
40
Tech
47
Quality
How is this score calculated?
Market Cap
$256.64M
Volume
158.08K
52W Range
$3.63 - $8.98
Target Price
$6.50

Company Overview

Mkt Cap$256.64MPrice$5.12
Volume158.08KChange+0.79%
P/E Ratio--Open$5.08
Revenue--Prev Close$5.08
Net Income--52W Range$3.63 - $8.98
Div YieldN/ATarget$6.50
Overall35Value20
Quality47Technical40

No chart data available

About Lifecore Biomedical Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

ABCD
1SymbolPriceChangeVol
2LFCR$5.12+0.8%158.08K
3
4
5
6

Get Lifecore Biomedical Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.